Biopharmaceutical Process Development - Considerations for Smarter and Faster Process Development

Author(s)Cytiva

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Biopharmaceutical Process Development - Considerations for Smarter and Faster Process Development

Newsletter

Related Content

mRNA development with quantitative expression analysis

Low-ng/mL quantitation of glucagon-like peptide-1 (GLP-1) analog in rat plasma

Sensitive LC-MRMHR approach for cyclic peptide quantitation in human plasma

Dos and Don’ts of oligonucleotide analysis

Low-pg/mL quantification of TL 13-112, a proteolysistargeting chimera (PROTAC) in rat plasma

Trending on BioPharm International

Charles River Incubator Cohort to Accelerate CGT Development

GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale

BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing

Navigating the Next Wave of Biopharma Manufacturing Innovation

FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways